Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724301 | SCV000228901 | pathogenic | not provided | 2014-12-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724301 | SCV001198576 | pathogenic | not provided | 2024-11-04 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 181 of the RHO protein (p.Glu181Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant retinitis pigmentosa (PMID: 1833777, 29068140). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 196282). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RHO protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RHO function (PMID: 8253795, 19913029). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074893 | SCV001240497 | pathogenic | Retinal dystrophy | 2019-08-13 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000177081 | SCV001440598 | pathogenic | Retinitis pigmentosa 4 | 2024-06-28 | criteria provided, single submitter | clinical testing | Criteria applied: PS3,PS4,PM1,PM2,PP3 |
Centre for Genomic Medicine, |
RCV000177081 | SCV001443228 | pathogenic | Retinitis pigmentosa 4 | 2020-09-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724301 | SCV001962524 | pathogenic | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | RHO: PP1:Strong, PM1, PM2, PS4:Moderate, PS3:Supporting |
Dept Of Ophthalmology, |
RCV001074893 | SCV004705660 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV001074893 | SCV005071447 | pathogenic | Retinal dystrophy | 2020-01-01 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV000504731 | SCV000598752 | likely pathogenic | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000177081 | SCV000804694 | pathogenic | Retinitis pigmentosa 4 | 2016-09-01 | no assertion criteria provided | clinical testing | |
Department of Clinical Genetics, |
RCV000504731 | SCV000926675 | pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research | |
Sharon lab, |
RCV000504731 | SCV001161245 | likely pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research | |
Clinical Genetics, |
RCV000724301 | SCV001978866 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000724301 | SCV001979581 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004755791 | SCV005362760 | pathogenic | RHO-related disorder | 2024-08-22 | no assertion criteria provided | clinical testing | The RHO c.541G>A variant is predicted to result in the amino acid substitution p.Glu181Lys. This variant has been reported many times as causative for autosomal dominant retinitis pigmentosa (see for examples: Dryja et al. 1991. PubMed ID: 1833777; Sohocki et al. 2001. PubMed ID: 11139241; Eisenberger et al. 2013. PubMed ID: 24265693: Table S4, Panneman et al. 2023. PubMed ID: 36819107). This variant has not been reported in the large population database gnomAD, indicating this variant is rare. This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/196282). Given the evidence, we interpret this variant as pathogenic for autosomal dominant disease. |